We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cipher Pharmaceuticals Inc | TSX:CPH | Toronto | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.27 | 3.11% | 8.95 | 8.85 | 8.95 | 9.00 | 8.67 | 8.67 | 26,194 | 21:15:01 |
MISSISSAUGA, ON, Aug. 5, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q2 2022 financial results on Thursday, August 11, 2022 after market close. The Company will also host a conference call on Friday, August 12, 2022 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: | August 12, 2022 |
TIME: | 8:30 a.m. ET |
DIAL-IN NUMBER: | (647) 484-0475 or (888) 220-8451 |
CONFERENCE ID: | 7538758 |
REPLAY DIAL-IN: | (888) 203-1112 (playback 7538758#) |
Expires August 19, 2022 | |
WEBCAST: | https://app.webinar.net/871ZpObNzYX |
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
Copyright 2022 Canada NewsWire
1 Year Cipher Pharmaceuticals Chart |
1 Month Cipher Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions